×

Composition for contraception

  • US 5,824,667 A
  • Filed: 10/31/1996
  • Issued: 10/20/1998
  • Est. Priority Date: 12/22/1993
  • Status: Expired
First Claim
Patent Images

1. A combination product for oral contraception, comprising(a) 23 or 24 dosage units, each containing an estrogen selected from>

  • 2.0 to 6.0 mg of 17β

    -estradiol and0.020 mg of ethinylestradiol;

    and a gestagen selected from0.25 to 0.30 mg of drospirenone and0.1 to 0.2 mg of cyproterone acetate,andb) 5 or 4, respectively, active ingredient-free placebo pills or other indications to show that the daily administration of the 23 or 24 dosage units respectively, is to be followed by 5 or 4, respectively pill-free or placebo pill days.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×